CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA

Clinical trial NCT07523009 · WITHDRAWN

Trial details

NCT number: NCT07523009
Sponsor: Peking Union Medical College Hospital
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia

Start date: 2026-06-01
Primary completion: 2028-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.